Back to Journals » Drug Design, Development and Therapy » Volume 19

Dexmedetomidine Attenuated Neuron Death, Cognitive Decline, and Anxiety-Like Behavior by Inhibiting CXCL2 in CA1 Region of AD Mice [Corrigendum]

Authors Ma K, An C, Li M, Zhang Y, Ren M , Wei Y, Xu W, Wang R, Bai Y, Zhang H, Liu X, Ji S, Chen X, Zhu K

Received 5 March 2025

Accepted for publication 5 March 2025

Published 17 March 2025 Volume 2025:19 Pages 2003—2004

DOI https://doi.org/10.2147/DDDT.S526425



Ma K, An C, Li M, et al. Drug Des Devel Ther. 2024;18:5351—5365.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 2 on page is incorrect. The trajectory map for the control group in Figure 2F is a duplication of the trajectory map in Figure 4E (AD+Dex group).

The correct Figure 2 is as follows.

Figure 2 Continued.

Figure 2 Dex attenuates the abnormal behavior of AD mice. (A) Schematic of experimental design. Aβ was injected into mouse brains on day 0 (D0); 7 days after Aβ injection, Dex was injected for 7 days. (B) The body weight of each mouse from D0 to D17 is shown in the line chart; body weight of mice at D20 is shown in the bar chart (n = 4 in each group); the ratio of brain weight to body weight is shown in the last bar chart (n = 5 in control and AD + Dex T2 groups, n = 6 in AD and AD + Dex T1 groups). (C) Trajectory diagram in the open-field test for each group; total distance, average speed, distance in center zone, and time in center zone were calculated and are shown in the bar graph (n = 7 in control group, n = 6 in AD + Dex T1 group, n = 8 in AD and AD + Dex T1 groups). (D) Bar graph showing the number of marbles buried in each group (n = 12 in control group, n = 10 in AD and AD + Dex T1 group, n = 8 in AD + Dex T2 group). (E) The alternation triplet was calculated and shown in the bar graph (n = 7 in control group, n = 8 in AD and AD + Dex T1 groups). (F) The percentage of time exploring new objects was calculated and is shown in the bar graph (n = 9 in control and AD groups, n = 10 in AD + Dex T1 group).

The authors apologize for this error and advise it does not affect the results and conclusions of the paper.


Read the original article


Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.